Advertisement

Related Videos

Varsha Gandhi, PhD, on Ibrutinib

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Opening Session Panel Discussion

Advertisement

Advertisement




Jan
16
Today In Oncology
Triplet Therapy Demonstrates Superior Progression-Free Survival in First-Line dMMR-MSI-H Metastatic Colorectal Cancer
Can Multimodal AI Models Predict Distant Recurrence Risk in Patients With Early Breast Cancer
HER2-Positive Gastroesophageal Cancer Zanidatamab Plus Chemotherapy Prolongs Progression-Free Survival
Improved Contralateral Breast Cancer Risk Knowledge With Personalized Counseling Tool
Machine Learning–Guided Optical Biopsy Accurately Identifies Malignant Lung Nodules Intraoperatively
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo